Transthyretin cardiac amyloidosis is increasingly recognized as an underdiagnosed cause of heart failure, particularly in older adults with increased ventricular wall thickness. Certain extracardiac manifestations can provide important diagnostic clues and should prompt consideration of a targeted evaluation. Test your clinical reasoning with this quick question on contemporary cardiac amyloidosis assessment! (Scroll down to answer the question) ##Disclaimer## The content provided on Docplexus is intended for educational purposes only.

While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including data visualization elements and graphics. We do not endorse any medical treatment, product, ideas, or service, including content from our industry partners. We do not associate with the views of…